1. Stocks
  2. Anebulo Pharmaceuticals Inc
  3. Swot
swot-logo

Anebulo Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Anebulo Pharmaceuticals Inc has 10 Strengths, 9 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Rising Momentum: Momentum Score Weekly Gainers

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Stock gained more than 20% in one month

Stock with Low PE (PE < = 10)

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Declining profits every quarter for the past 2 quarters

Top Losers

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Stocks rising sharply on very low month volumes

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks